InDex Pharmaceuticals has been granted a new patent in Europe for the commercial formulation of cobitolimod ...Middle East

PR Newswire - News
STOCKHOLM, Aug. 2, 2023 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced that a new formulation patent for the drug candidate cobitolimod has been granted by the European Patent Office. The patent provides protection of the enema formulation of cobitolimod, that is...

Read More Details
Finally We wish PressBee provided you with enough information of ( InDex Pharmaceuticals has been granted a new patent in Europe for the commercial formulation of cobitolimod )

Apple Storegoogle play

Also on site :

Most viewed in News